-
- Posts: 1
- Joined: Wed Aug 15, 2012 12:33 am
Advertisement
Manual Integration - FDA/ICH Guidance Documents
Discussions about HPLC, CE, TLC, SFC, and other "liquid phase" separation techniques.
3 posts
Page 1 of 1
Does anyone know if there are any FDA or ICH guidance documents on the subject of "Manual Integration"?
-
- Posts: 2175
- Joined: Tue Aug 17, 2004 7:59 pm
I'm fairly certain that there are not. Integration has to be consistent and defensible. If it is covered by your SOPs, follow them. If you suspect that there are abuses via manual integration and there is no SOP covering this, maybe it's time to suggest one.
Thanks,
DR

DR

-
- Posts: 621
- Joined: Tue Nov 27, 2007 1:20 pm
Certainly, in bioanalysis peak for FDA submission reintegration is permitted. However a full written justification is required in each case and the result has to be signed off by the lab manager.
This eliminates reintegration to tweak perceived low/high results or to obtain better replication.
I've even used mock exercises to assess the ability of staff to set integration markers on peaks to a similar standard before signing off on their ability to perform reintegration.
"Sample Data Reintegration: An SOP or guideline for sample data reintegration should be
established. This SOP or guideline should explain the reasons for reintegration and how the
reintegration is to be performed. The rationale for the reintegration should be clearly
described and documented. Original and reintegration data should be reported."
Taken from http://www.fda.gov/downloads/Drugs/.../ ... 070107.pdf However it could apply to any analysis no just bioanalytical
This eliminates reintegration to tweak perceived low/high results or to obtain better replication.
I've even used mock exercises to assess the ability of staff to set integration markers on peaks to a similar standard before signing off on their ability to perform reintegration.
"Sample Data Reintegration: An SOP or guideline for sample data reintegration should be
established. This SOP or guideline should explain the reasons for reintegration and how the
reintegration is to be performed. The rationale for the reintegration should be clearly
described and documented. Original and reintegration data should be reported."
Taken from http://www.fda.gov/downloads/Drugs/.../ ... 070107.pdf However it could apply to any analysis no just bioanalytical
Good judgment comes from bad experience, and a lot of that comes from bad judgment.
3 posts
Page 1 of 1
Who is online
In total there are 21 users online :: 2 registered, 0 hidden and 19 guests (based on users active over the past 5 minutes)
Most users ever online was 4374 on Fri Oct 03, 2025 12:41 am
Users browsing this forum: Ahrefs [Bot], Baidu [Spider] and 19 guests
Most users ever online was 4374 on Fri Oct 03, 2025 12:41 am
Users browsing this forum: Ahrefs [Bot], Baidu [Spider] and 19 guests
Latest Blog Posts from Separation Science
Separation Science offers free learning from the experts covering methods, applications, webinars, eSeminars, videos, tutorials for users of liquid chromatography, gas chromatography, mass spectrometry, sample preparation and related analytical techniques.
Subscribe to our eNewsletter with daily, weekly or monthly updates: Food & Beverage, Environmental, (Bio)Pharmaceutical, Bioclinical, Liquid Chromatography, Gas Chromatography and Mass Spectrometry.
- Follow us on Twitter: @Sep_Science
- Follow us on Linkedin: Separation Science
